West China Journal of Stomatology

Previous Articles     Next Articles

Evaluation of gingival inflammation r elated to differ ent r etr action agents

SUN Xue - wu1, SUN Gui - lan2, XIAO Li - jing1   

  1. 1. Dept. of Prosthodontics, Yantai Oral Hospital, Yantai 264000, China; 2. Dept. of Dentistry, Medical College of Qingdao University, Qingdao 266000, China
  • Received:2008-02-25 Revised:2008-02-25 Online:2008-02-20 Published:2008-02-20
  • Contact: SUN Gui - lan,Tel:0532- 5956568

Abstract:

Objective To choose the best retraction agent for the clinic by evaluating the gingival inflammation related to three kinds of retraction agents. Methods 40 maxillary premolars were divided into four groups according to the randomized block design: Ferric sulfate group, aluminum chloride group, epinephrine group, sodium chloride group(control group), each 10 teeth, respectively used 25% AlCl3, 15.5% Fe2 (SO4)3, 0.1% HCl- epinephrine, sodium chloride as retraction agents. The quantity of gingival crevicular fluid(GCF) and the active level of aspartate aminotransferase(AST) in gingival crevicular fluid were measured before and 1, 3, 5, 7, 9 days after retracting gingiva by four kinds retraction agents. The changes of GCF were calculated. Results The change of the GCF from the smallest to the largest was sodium chloride, 0.1% HCl - epinephrine, 25% AlCl3 , 15.5% Fe2 (SO4)3. Compared withsodium chloride, only 15.5% Fe2 (SO4)3 in AST was the significant difference in the first day and the third day(P<0.05). AST of ferric sulfate group after 1, 3 days greater than 800 IU. Conclusion 0.1% HCl - epinephrine is suggested in patient without cardiovascular disease. For patient with cardiovascular disease, the better substitute is 25% AlCl3. 15.5% Fe2 (SO4)3 will not be used until its concentration is fallen.

Key words: retraction agent, gingival crevicular fluid, gingival inflammation, aspartate aminotransferase